Point72 Middle East FZE’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-3,440
| Closed | -$3.02M | – | 756 |
|
|
2023
Q4 | $3.02M | Buy |
3,440
+2,612
| +315% | +$2.29M | 0.09% | 130 |
|
|
2023
Q3 | $681K | Buy |
+828
| New | +$681K | 0.02% | 355 |
|
|
2023
Q2 | – | Sell |
-301
| Closed | -$247K | – | 1443 |
|
|
2023
Q1 | $247K | Sell |
301
-15,295
| -98% | -$12.6M | 0.01% | 429 |
|
|
2022
Q4 | $11.3M | Buy |
+15,596
| New | +$11.3M | 0.49% | 12 |
|